Ellevest, Inc. Kala Pharmaceuticals, Inc. Transaction History

Ellevest, Inc.

  • $1.61 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 26, 2020
SELL
$7.5 - $11.11 $112 - $166
-15 Closed
0 $0
Q2 2020

Jul 06, 2020
BUY
$8.33 - $13.79 $124 - $206
15 New
15 $0

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $9.82M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Ellevest, Inc. Portfolio

Follow Ellevest, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email